Direkt zum Inhalt
Merck

GE17-3717-01

Capto S ImpAct

Cytiva 17-3717-01, pack of 25 ml

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
23151817
NACRES:
NA.56

ligand

(-SO3)

Hersteller/Markenname

Cytiva 17-3717-01

Matrix

high-flow agarose

Durchschnittliche Teilgröße

50 μm (d50V)

cleaning in place

4-12

working range

3-14

Kapazität

binding capacity(>85 mg BSA/mL medium, >90 mg lysozyme/ml medium, >100 mg IgG/ ml medium)

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Verwandte Kategorien

Allgemeine Beschreibung

This chromatography medium is part of our platform of high-resolution media based on the Capto product line. The polymeric ligand, in combination with the attributes of the base matrix, gives this cation exchanger a high binding capacity. Furthermore, the small bead size enables high-resolution purifications.

The high-flow characteristics of Capto media allows for excellent pressure-flow properties. The exceptional binding capacity and resolution of Capto S ImpAct, combined with the ability to run at high flow rates and bed heights, increase productivity and flexibility in process design.

Capto S ImpAct is a BioProcess chromatography medium developed for large-scale purification of biopharmaceutical proteins. Based on the well-established Capto base matrix, it provides many opportunities for improved productivity and straightforward process development.

Capto S ImpAct is available in a range of different bulk pack sizes and convenient prepacked formats for easy scale-up and process development. As a member of the BioProcess media range, Capto S ImpAct meets industrial demands with security of supply and comprehensive technical and regulatory support.

Leistungsmerkmale und Vorteile

Capto S ImpAct is a strong cation exchange chromatography medium (resin) developed for intermediate purification and polishing of monoclonal antibodies (MAbs) and other biomolecules.

  • High binding capacity, > 100 mg MAb/mL medium.
  • Efficient aggregate removal at high load of monoclonal antibodies.
  • High-resolution intermediate purification and polishing based on the well-established Capto platform.
  • Flexibility of design thanks to a large operational window of flow rates and bed heights for easy optimization and scaling.
  • High productivity enabling cost-efficient manufacturing.
  • Security of supply and comprehensive regulatory support.

Hinweis zur Analyse

To view the Certificate of Analysis for this product, please visit www.cytiva.com.

Rechtliche Hinweise

Capto is a trademark of Cytiva

Lagerklassenschlüssel

3 - Flammable liquids


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.